‌

US Patent 11752190 Modulators of complement activity

Patent 11752190 was granted and assigned to Ra Pharmaceuticals on September, 2023 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors

Is a

Patent attributes

Patent Applicant

Ra Pharmaceuticals

Current Assignee

Ra Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

Patent Inventor Names

Grace Victoria Parker

Sylvia Tobe

Alonso Ricardo

Michelle Denise Hoarty

Steven James DeMarco

Douglas A. Treco

Date of Patent

September 12, 2023

Patent Application Number

17065560

Date Filed

October 8, 2020

Patent Citations

US Patent 8652477 Methods for treating disseminated intravascular coagulation by inhibiting MASP-2 dependent complement activation

US Patent 8703136 Complement inhibition for improved nerve regeneration

US Patent 8753625 Use of complement inhibitors to treat ocular diseases

US Patent 8911733 Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

US Patent 9937222 Modulators of complement activity

US Patent 10106579 Modulation of complement activity

US Patent 10208089 Modulation of complement activity

US Patent 10328115 Modulators of complement activity

...

Patent Primary Examiner

Sudhakar Katakam

The present invention relates to polypeptide modulators of complement activity, including cyclic polypeptide modulators. Included are methods of utilizing such modulators as therapeutics.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 11752190 Modulators of complement activity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Golden Query Tool

By using this site, you agree to our Terms of Service.